The History Of Vaccine Usage For Treating Lymphoma

Lymphoma is an often-deadly disease that can affect anyone regardless of age, race, or lifestyle. It’s a disease in which the lymphatic system of the body is invaded by cancerous cells which may spread throughout the system from lymph node to lymph node, eventually spreading to organs such as the stomach, liver, and even the brain. To that end, much research has been done in the quest for finding a cure for this troublesome affliction. One type of research that is showing some efficiency when it comes to fighting the disease is vaccine research. Vaccines have been used throughout history to help to eradicate such disease as polio and small-pox. The basic principle of vaccines works like this: the body can better understand how to fight an invader off if it is exposed to a small amount of the invasive entity. To that end, people get injected with small amounts of different diseases in order to teach their body exactly how to fight off that type of attacker.

            Those who have lymphoma have long awaited the possibility of some sort of treatment that can eliminate the disease with little damage to their healthy cells. Current treatments such as radiotherapy and chemotherapy have shown to be troublesome when it comes to eliminating lymphoma. While they can effectively attack the disease, chemotherapy can cause numerous side effects including a loss of hair, nausea, and a host of other problems. A new frontier is in sight, however, with the advent of vaccines engineered specifically to deal with Non-Hodgkin’s lymphoma.

            Dr. Fred Butler of Investigative Clinical Research of Indiana is one of many scientists who are working towards developing a proper vaccine. His vaccine is known as BiovaxID, and it works in a way that is unfamiliar to many. To begin, Butler takes a sample of the cancerous cells found in the patient. Then, he takes some of the cells that are located in the tumor and fuses them together with specifically engineered cells in order to show the immune system exactly what it needs to do to fight off the tumor. Butler hopes to use the vaccine in union with chemotherapy treatment in order to give the patient the proper care they need to make a full recovery. Work on the drug has begun, and it has reached a trial stage of clinical testing. Hopefully, the results will show that there’s a new hope for those with lymphoma. The more methods that we have of dealing with this disease, the better chance that we have of being able to create a custom treatment program tailored to meet a patient’s specific needs. The vaccine is expected to be used between five and six times throughout the course of a patients treatment in order to ensure that the body knows exactly how to fight the disease. If you’d like to know more about the advent of this vaccine, you can visit Dr. Butler’s website at www.biovest.com. The site provides a wealth of information regarding the research and expected outcome of this vaccine.